ClosedFor profitRedwood City, United States
CardioDx
CardioDx is a cardiovascular genomic diagnostics company providing clinicians with information to enhance patient care.
- Founded
- 2004 22 years ago
- Staff
- 51-100 band, as listed
- Followers
- - on LinkedIn
- Funding
- $337M as listed, currency not stated
Set against six million companies
Size
51-100 people: larger than 75% of companies with a size listed
Age
22 years old.
Reach
Website ranked #12,536,644 in the world for traffic, about 100 visits a month.
What it does
BiotechnologyGeneticsHealth CareHealth DiagnosticsPharmaceutical
Funding, as listed
$337M currency not stated
- Rounds12
- LatestSeries unknown, Jan 2017
- Investors21, 1 leading
What the source datasets report. We have not watched these rounds ourselves.
Every detail we hold
Everything the source datasets list about CardioDx, field by field. Contact details are held but never shown.
The company
- Name
- CardioDx
- Type
- For profit
- Status
- Closed
- Founded
- 2004
- Founders
- David Levison
- Categories
- Biotechnology, Genetics, Health Care, Health Diagnostics, Pharmaceutical
Where
- City
- Redwood City
- Country
- United States
- Markets
- San Francisco Bay Area, Silicon Valley, West Coast, Western US
Size and reach
- Staff band
- 51-100
- Web traffic rank
- #12,536,644
- Monthly web visits
- 100
Funding, as listed
- Total
- 337,261,831 (currency not stated)
- Rounds
- 12
- Latest round
- Series unknown
- Latest round date
- Jan 2017
- Investors
- 21
- Lead investors
- 1
- Listing status
- private
About this record
- Sources
- Crunchbase
- Last imported
- Sept 2026
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 1,637,054 companies in United States and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.